{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:15:32Z","timestamp":1760300132951},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31600269"],"award-info":[{"award-number":["31600269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alpha-momorcharin (\u03b1-MC), a type I ribosome-inactivating protein (RIP) isolated from <jats:italic>Momordica charantia<\/jats:italic> seeds, has been extensively studied for its antitumor, antiviral and antifungal activities. However, as an exogenous protein, problems associated with short half-life and strong immunogenicity have limited its clinical application. Poly (ethylene glycol) (PEG), as a polyether compound, is a well established and efficient modifier to develop it as a potential agent. Nevertheless, conventional PEGylation is not site-controlled and the conjugates are often not homogenous due to the generation of multi-PEGylated derivatives. To obtain a homogenous mono-PEGylated \u03b1-MC, the PEGylation was carried out by coupling a 20 kDa\u00a0mPEG-butyraldehyde (mPEG-ALD) with \u03b1-MC. The product was separated and purified by MacroCap SP chromatography. Results from SDS-PAGE and MALDI-TOF MS revealed that the PEGylated \u03b1-MC consisted of one molecule mPEG and \u03b1-MC. Edman degradation confirmed that the <jats:italic>N<\/jats:italic>-terminal residue of \u03b1-MC was successfully coupled with mPEG-ALD. The mono-PEGylated \u03b1-MC possessed an extremely similar secondary structure to native \u03b1-MC through spectral analyses. In addition, it also showed low immunogenicity by double immunodiffusion and preserved moderate antitumor activity to three kinds of tumor cell lines <jats:italic>in vitro<\/jats:italic>. Finally, trypsin resistance was also considerably improved.<\/jats:p>","DOI":"10.1038\/s41598-018-35969-1","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T18:04:12Z","timestamp":1543860252000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chemosynthesis and characterization of site-specific N-terminally PEGylated Alpha-momorcharin as apotential agent"],"prefix":"10.1038","volume":"8","author":[{"given":"Wenkui","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfa","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"35969_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.toxicon.2013.02.005","volume":"67","author":"F Stirpe","year":"2013","unstructured":"Stirpe, F. Ribosome-inactivating proteins: From toxins to useful proteins. Toxicon 67, 12\u201316 (2013).","journal-title":"Toxicon"},{"key":"35969_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00253-012-3886-6","volume":"96","author":"S Wang","year":"2012","unstructured":"Wang, S. et al. Molecular cloning and functional analysis of a recombinant ribosome-inactivating protein (alpha-momorcharin) from Momordica charantia. Appl. Microbiol. Biotechnol. 96, 939\u2013950 (2012).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"35969_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0969-2126(00)00004-6","volume":"2","author":"J Ren","year":"1994","unstructured":"Ren, J. et al. The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of \u03b1-momorcharin. Structure 2, 7\u201316 (1994).","journal-title":"Structure"},{"key":"35969_CR4","doi-asserted-by":"publisher","first-page":"E1588","DOI":"10.3390\/molecules21111588","volume":"21","author":"WW Shi","year":"2016","unstructured":"Shi, W. W. et al. Structures and Ribosomal Interaction of Ribosome-Inactivating Proteins. Molecules 21, E1588 (2016).","journal-title":"Molecules"},{"key":"35969_CR5","doi-asserted-by":"publisher","first-page":"E134","DOI":"10.3390\/toxins9100314","volume":"9","author":"MS Fabbrini","year":"2017","unstructured":"Fabbrini, M. S. et al. Plant ribosome-inactivating proteins: Progesses, challenges and biotechnological applications (and a few digressions). Toxins (Basel). 9, E134 (2017).","journal-title":"Toxins (Basel)."},{"key":"35969_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0272-1","volume":"23","author":"E Pizzo","year":"2016","unstructured":"Pizzo, E. & Di Maro, A. A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): From bioconjugate to nanoconstructs. J. Biomed. Sci. 23, 1\u20138 (2016).","journal-title":"J. Biomed. Sci."},{"key":"35969_CR7","first-page":"1","volume":"34","author":"M Zeng","year":"2015","unstructured":"Zeng, M. et al. Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins. Chin. J. Cancer 34, 1\u201310 (2015).","journal-title":"Chin. J. Cancer"},{"key":"35969_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1042\/bj2910749","volume":"291","author":"S Magn\u00fasson","year":"1993","unstructured":"Magn\u00fasson, S. & Berg, T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem. J. 291, 749\u2013755 (1993).","journal-title":"Biochem. J."},{"key":"35969_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1104\/pp.107.4.1323","volume":"107","author":"TD Hey","year":"1995","unstructured":"Hey, T. D. et al. Maize ribosome-inactivating protein (b-32). Homologs in related species, effects on maize ribosomes, and modulation of activity by pro-peptide deletions. Plant Physiol. 107, 1323\u20131332 (1995).","journal-title":"Plant Physiol."},{"key":"35969_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2174\/156652409789839071","volume":"9","author":"M Puri","year":"2009","unstructured":"Puri, M. et al. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr. Mol. Med. 9, 1080\u20131094 (2009).","journal-title":"Curr. Mol. Med."},{"key":"35969_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1039\/C6FO01812B","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Momordica charantia: a popular health-promoting vegetable with multifunctionality. Food Funct. 8, 1749\u20131762 (2017).","journal-title":"Food Funct."},{"key":"35969_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00425-012-1746-3","volume":"237","author":"F Zhu","year":"2013","unstructured":"Zhu, F. et al. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro. Planta 237, 77\u201388 (2013).","journal-title":"Planta"},{"key":"35969_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/abbs\/gmp068","volume":"41","author":"M Li","year":"2009","unstructured":"Li, M. et al. Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol. Acta Biochim. Biophys. Sin. (Shanghai). 41, 792\u2013799 (2009).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"35969_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bcp.2014.03.004","volume":"89","author":"WL Pan","year":"2014","unstructured":"Pan, W. L. et al. Preferential cytotoxicity of the type i ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. Biochem. Pharmacol. 89, 329\u2013339 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"35969_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jep.2011.11.057","volume":"139","author":"Y Meng","year":"2012","unstructured":"Meng, Y. et al. Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats. J. Ethnopharmacol. 139, 590\u2013598 (2012).","journal-title":"J. Ethnopharmacol."},{"key":"35969_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2012.09.025","volume":"64","author":"MJ Roberts","year":"2012","unstructured":"Roberts, M. J. et al. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 64, 116\u2013127 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"35969_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0024-3205(99)00048-X","volume":"64","author":"XH He","year":"1999","unstructured":"He, X. H. et al. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity. Life Sci. 64, 1163\u20131175 (1999).","journal-title":"Life Sci."},{"key":"35969_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-409X(95)00023-Z","volume":"16","author":"S Zalipsky","year":"1995","unstructured":"Zalipsky, S. Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv. Drug Deliv. Rev. 16, 157\u2013182 (1995).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"35969_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"FM Veronese","year":"2015","unstructured":"Veronese, F. M. & Pasult, G. PEGylation, successful approach to drug delivery. Drug Discov. Today. 10, 1451\u20131458 (2015).","journal-title":"Drug Discov. Today."},{"key":"35969_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0169-409X(02)00180-1","volume":"55","author":"RB Greenwald","year":"2003","unstructured":"Greenwald, R. B. et al. Effective drug delivery by PEGylation drug conjugates. Adv.Drug Deliv. Rev. 55, 217\u2013250 (2003).","journal-title":"Adv.Drug Deliv. Rev."},{"key":"35969_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","volume":"161","author":"G Pasut","year":"2012","unstructured":"Pasut, G. & Veronese, F. M. State of the art in PEGylation: the great versatility achieved after forty years of research. J. Control Release. 161, 461\u2013472 (2012).","journal-title":"J. Control Release."},{"key":"35969_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10529-010-0242-8","volume":"32","author":"X Bian","year":"2010","unstructured":"Bian, X. et al. PEGylation of alpha-momorcharin: Synthesis and characterization of novel anti-tumor conjugates with therapeutic potential. Biotechnol. Lett. 32, 883\u2013890 (2010).","journal-title":"Biotechnol. Lett."},{"key":"35969_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3109\/08923973.2012.666979","volume":"34","author":"JC Zheng","year":"2012","unstructured":"Zheng, J. C. et al. PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of \u03b1-momorcharin in vivo. Immunopharmacol. Immunotoxicol. 34, 866\u2013873 (2012).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"35969_CR24","first-page":"3133","volume":"7","author":"Y Meng","year":"2012","unstructured":"Meng, Y. et al. Preparation of an antitumor and antivirus agent: Chemical modification of \u03b1-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol. Int. J. Nanomedicine 7, 3133\u20133142 (2012).","journal-title":"Int. J. Nanomedicine"},{"key":"35969_CR25","doi-asserted-by":"publisher","first-page":"25831","DOI":"10.3390\/ijms161025831","volume":"16","author":"JK Dozier","year":"2015","unstructured":"Dozier, J. K. & Distefano, M. D. Site-specific pegylation of therapeutic proteins. Int. J. Mol. Sci. 16, 25831\u201325864 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"35969_CR26","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.2174\/1381612822666160204120547","volume":"22","author":"P Sawhney","year":"2016","unstructured":"Sawhney, P. et al. Site-Specific Thiol-mediated PEGylation of Streptokinase Leads to Improved Properties with Clinical Potential. Curr. Pharm. Des. 22, 5868\u20135878 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"35969_CR27","first-page":"967","volume":"46","author":"O Schiavon","year":"1991","unstructured":"Schiavon, O. et al. Surface modification of enzymes for therapeutic use: monomethoxypoly (ethylene glycol) derivatization of ribonuclease. Farmaco. 46, 967\u2013978 (1991).","journal-title":"Farmaco."},{"key":"35969_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bioeng.2007.10.002","volume":"24","author":"Q An","year":"2007","unstructured":"An, Q. et al. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics. Biomol. Eng. 24, 643\u2013649 (2007).","journal-title":"Biomol. Eng."},{"key":"35969_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.bbrc.2004.03.139","volume":"317","author":"JH Wang","year":"2004","unstructured":"Wang, J. H. et al. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro. Biochm. Biophys. Res. Commun. 317, 965\u2013971 (2004).","journal-title":"Biochm. Biophys. Res. Commun."},{"key":"35969_CR30","doi-asserted-by":"publisher","first-page":"E1457","DOI":"10.3390\/molecules21111457","volume":"21","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity. Molecules 21, E1457 (2016).","journal-title":"Molecules"},{"key":"35969_CR31","first-page":"30","volume":"18","author":"ES James","year":"2005","unstructured":"James, E. S. et al. Making site-specific PEGylation work. Purification and analysis of PEGylated protein pharmaceuticals presents many challenges. BioPharm. International. 18, 30\u201341 (2005).","journal-title":"BioPharm. International."},{"key":"35969_CR32","first-page":"341","volume":"22","author":"JM Harris","year":"1984","unstructured":"Harris, J. M. et al. Synthesis and characterization of poly (ethylene glycol) derivatives. J. Poly. Sci: Polymer Chem. Ed. 22, 341\u2013352 (1984).","journal-title":"J. Poly. Sci: Polymer Chem. Ed."},{"key":"35969_CR33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1023\/A:1016042220817","volume":"13","author":"O Kinstler","year":"1996","unstructured":"Kinstler, O. et al. Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 13, 996 (1996).","journal-title":"Pharm. Res."},{"key":"35969_CR34","first-page":"565","volume":"38","author":"WJ Fung","year":"1997","unstructured":"Fung, W. J. et al. Strategies for the preparation and characterization of polyethylene glycol(PEG) conjugated pharmaceutical proteins. Polym. Prepr. 38, 565\u2013566 (1997).","journal-title":"Polym. Prepr."},{"key":"35969_CR35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"},{"key":"35969_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H. et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"35969_CR37","first-page":"3","volume":"9","author":"Y Meng","year":"2014","unstructured":"Meng, Y. et al. A novel method for simultaneous production of two ribosome-inactivating proteins,\u202f\u03b1-MMC and MAP30, from Momordica charantia L. PLoS One 9, 3\u20139 (2014).","journal-title":"PLoS One"},{"key":"35969_CR38","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1248\/bpb.b13-00132","volume":"36","author":"JS Kang","year":"2013","unstructured":"Kang, J. S. & Lee, K. C. In vivo pharmacokinetics and pharmacodynamics of poisitional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats. Biol. Pharm. Bull. 36, 1146\u20131151 (2013).","journal-title":"Biol. Pharm. Bull."},{"key":"35969_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF03261880","volume":"26","author":"C Zhang","year":"2012","unstructured":"Zhang, C. et al. Site-specific PEGylation of therapeutic proteins via optimization of both accessible reactive amino acid residues and PEG derivatives. BioDrugs. 26, 209\u2013215 (2012).","journal-title":"BioDrugs."},{"key":"35969_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(92)90460-O","volume":"200","author":"MM Kurfurst","year":"1992","unstructured":"Kurfurst, M. M. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 200, 244\u2013248 (1992).","journal-title":"Anal. Biochem."},{"key":"35969_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1399-3011.1992.tb00787.x","volume":"39","author":"JS Fruton","year":"1992","unstructured":"Fruton, J. S. An episode in the history of protein chemistry: Pehr Edman\u2019s method for the sequential degradation of peptides. Int. J. Pept. Protein Res. 39, 189\u2013194 (1992).","journal-title":"Int. J. Pept. Protein Res."},{"key":"35969_CR42","doi-asserted-by":"publisher","first-page":"2.3.1","DOI":"10.1002\/cpim.18","volume":"116","author":"P Hornbeck","year":"2017","unstructured":"Hornbeck, P. Double-immunodiffusion assay for detecting specific antibodies (Ouchterlony). Curr. Protoc. Immunol. 116, 2.3.1\u20132.3.4 (2017).","journal-title":"Curr. Protoc. Immunol."},{"key":"35969_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1081-1206(10)61187-8","volume":"95","author":"DW Goetz","year":"2005","unstructured":"Goetz, D. W. et al. Cross-reactivity among edible nuts: double immunodiffusion, cross immunoelectrophoresis, and human specific IgE serologic surveys. Ann. Allergy Asthma.Immunol. 95, 45\u201352 (2005).","journal-title":"Ann. Allergy Asthma.Immunol."},{"key":"35969_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1081-1206(10)62746-9","volume":"84","author":"LA Schwietz","year":"2000","unstructured":"Schwietz, L. A. et al. Cross-reactivity among conifer pollens. Ann. Allergy Asthma. Immunol. 84, 87\u201393 (2000).","journal-title":"Ann. Allergy Asthma. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35969-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T12:22:51Z","timestamp":1671625371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35969-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35969-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17729"}}